This page shows the latest Tregs news and features for those working in and with pharma, biotech and healthcare.
In a humanised mouse model, it was shown that while targeting the T-cell receptor, orally administered Foralumab modulates immune responses of the T-cells and enhances regulatory T-cells (Tregs),
In a humanised mouse model, it was shown that while targeting the T-cell receptor, orally administered foralumab modulates immune responses of the T-cells and enhances regulatory T-cells (Tregs),
In a humanised mouse model, it was shown that while targeting the T-cell receptor, orally administered Foralumab modulates immune responses of the T-cells and enhances regulatory T-cells (Tregs), ... Based on these studies, the intranasal and oral
In a humanised mouse model, it was shown that while targeting the T-cell receptor, orally administered foralumab modulates immune responses of the T-cells and enhances regulatory T-cells (Tregs), ... Based on these studies, the intranasal and oral
Bristol Myers Squibb (BMS) and GentiBio have announced a multi-year partnership to develop new regulatory T-cell (Treg) therapies to re-establish immune tolerance and repair tissue in patients living ... BMS will use its experience in cell therapies and
Leading Pandion’s pipeline is an engineered IL-2 mutein fused to a protein backbone – known as PT101 – that is designed to selectively activate and expand regulatory T cells (Tregs) for ... Tregs can inhibit the activity of several different
More from news
Approximately 1 fully matching, plus 12 partially matching documents found.
Although described as an acquisition, the deal covers two products, including an anti-CD25 antibody that depletes regulatory T‐cells (Tregs) while preserving IL‐2 binding and signalling on effector ... Tregs) while preserving effector T‐cells (Teffs
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
French biotech company TxCell has appointed François Meyer as its executive chairman as it completes a strategic realignment around its CAR-Treg research programmes. ... We can now look to the future with great expectations and with one major objective
Dr Zhou will lead the team's discovery and engineering activities on Chimeric Antigen Receptor in Treg cells ( CAR-Treg) for immunotherapy of severe chronic autoimmune and inflammatory diseases and organ ... Cell engineering significantly broadens the
leadership in the promising field of Treg Cells.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
For example, the relevant immune mechanisms associated with clinical progression of HCC include increased tumor-infiltrating regulatory T cells (Tregs) and M2-polarized tumor-associated macrophages (TAMs), which can establish immune ... TILs) to Tregs as
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...